A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
for COVID-19
Sites in Los Angeles & San Francisco
Sponsor: Kara Chew
Sex: All·Age: 40 - 64·Accepts healthy volunteers
Code: NCT06810934·Phase 1, Phase 2·Recruiting·Listed Feb 2025